AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Stada Prepares for Imminent IPO, Valuation Expected to Reach €10-12bn
ByAinvest
Monday, Mar 17, 2025 7:36 am ET1min read
Stada, a German drug manufacturer, is preparing for an imminent IPO. The announcement could be made as early as Wednesday, with a potential valuation of €10-12 billion. The company, majority-owned by Bain Capital and Cinven, aims to raise around €1.5 billion from the sale of shares. If the IPO is successful, Stada could join the MDax or DAX index.
Stada Arzneimittel AG, a German drug manufacturer with a consumer health-focused pipeline, is reportedly preparing for an initial public offering (IPO) [1]. The highly anticipated announcement could be made as early as Wednesday, with a potential valuation of €10-12 billion [1]. This potential listing would allow the company to raise approximately €1.5 billion from the sale of shares [1].If successful, Stada would join the MDax or DAX index, two prestigious German stock market indices [2]. The company is majority-owned by private equity firms Bain Capital and Cinven, who are seeking to bolster Stada's pipeline ahead of the sale [1].
According to sources familiar with the matter, Barclays Plc, Citigroup Inc., HSBC Holdings Plc, Jefferies Financial Group Inc., and UBS Group AG have been selected as the bookrunners for the potential IPO [1]. Deutsche Bank AG and Goldman Sachs Group Inc. have also been added as global coordinators [1].
The decision to pursue an IPO comes after negotiations over a potential sale of Stada to rival investment firm GTCR cooled [1]. Stada's private equity owners, Bain Capital and Cinven, have been encouraged by the recent market rally and are considering filing the intention to float document early next year [1].
An IPO of Stada would rank as one of the biggest health-care transactions in Europe in recent years [1]. This move comes as a growing number of German firms gear up to go public despite concerns over Europe's largest economy [3].
Sources:
[1] + https://www.bnnbloomberg.ca/business/2024/11/08/stada-picks-ipo-bookrunners-eyes-kickoff-early-next-year/
[2] + https://www.frankfurt-stock-exchange.de/en/market-data/market-data-equities/german-stock-market-indices/
[3] + https://www.reuters.com/business/eu/german-companies-gear-up-ipos-amid-economic-uncertainty-2021-11-05/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet